SRS Capital Advisors »

Enlivex Therapeutics shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Enlivex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enlivex Therapeutics held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enlivex Therapeutics by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.0k 615 1.68
2024-06-30 $873 615 1.42
2023-06-30 $762 290 2.63
2022-06-30 $1.0k 140 7.14

More positions owned by SRS Capital Advisors

Vanguard Index Fds Value Etf (VTV)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Schwab Strategic Tr Us Tips Etf (SCHP)
Vanguard Index Fds Growth Etf (VUG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Vanguard Index Fds Mid Cap Etf (VO)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr S&p 500 Val Etf (IVE)

View all positions for SRS Capital Advisors

Top funds holding Enlivex Therapeutics

Armistice Capital
Morgan Stanley
Renaissance Technologies
Citadel Advisors
Goldman Sachs Group
Geode Capital Management
Wells Fargo & Company
Group One Trading
Steward Partners Investment Advisory
Signature
Jpmorgan Chase & Co
Activest Wealth Management
SRS Capital Advisors
Advisor Group Holdings
Red Tortoise

View all funds holding Enlivex Therapeutics